Clinical Trial Update: Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two stem cell dose regimens to reduce transplant-induced symptom burden in patients with multiple myeloma or primary amyloidosis; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Multiple Myeloma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma, Primary Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2020-01-14